Compatibility of carotid stenting and cardiac surgery [8]

Stroke

Volumn 37, Issue 5, 2006, Pages 1153-1154

  Dalainas, Ilias ^a   Nano, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; BLEEDING; CAROTID ARTERY; CAROTID ARTERY STENTING; CLINICAL TRIAL; HEART SURGERY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LETTER; PRIORITY JOURNAL; STENT; STROKE;

ASPIRIN; BLOOD LOSS, SURGICAL; CAROTID ARTERIES; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; STENTS; THORACIC SURGICAL PROCEDURES; TIME FACTORS;

EID: 33646697360     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000217460.70676.fd     Document Type: Letter

References (3)

1. Randall MS, McKevitt FM, Cleveland TJ, Gaines PA, Venables GS. Is there any benefit from staged carotid and coronary revascularization using carotid stents? A single-center experience highlights the need for a randomized controlled trial. Stroke. 2006;37:435-439.
2. McKevitt FM, Randall MS, Cleveland TJ, Gaines PA, Tan KT, Venables GS. The benefits of combined anti-platelet treatment in the carotid artery stenting. Eur J Vasc Endovasc Surg. 2005;29:522-527.
3. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol. 2000;35:157-163.